ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,516Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 487

$341K Total Retail Price of All Prescriptions

Rank: 110 out of 487

305 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 305 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 305 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,868 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
SIMVASTATIN 278 236 1 4
LEVOTHYROXINE SODIUM 272 250 2 1
LISINOPRIL 244 217 3 5
OMEPRAZOLE 242 187 4 2
HYDROCODONE-ACETAMINOPHEN 236 151 S3 5 3
FUROSEMIDE 233 211 6 7
WARFARIN SODIUM 224 214 7 11
POTASSIUM CHLORIDE 219 181 8 10
GABAPENTIN 196 125 9 13
TRIAMTERENE-HCTZ 156 132 10 49
AMLODIPINE BESYLATE 141 127 11 6
TAMSULOSIN HCL 117 110 12 25
HYDROCHLOROTHIAZIDE 112 74 13 9
METOPROLOL TARTRATE 109 94 14 17
TRAMADOL HCL 109 91 14 19
ZOLPIDEM TARTRATE 107 75 16 14
METFORMIN HCL 106 90 17 8
DIVALPROEX SODIUM 95 69 18 86
RISPERIDONE 85 60 19 58
AMITRIPTYLINE HCL 84 56 R 20 45
CITALOPRAM HBR 78 65 21 12
METOPROLOL SUCCINATE 76 76 22 15
LOVASTATIN 73 52 23 30
ATORVASTATIN CALCIUM 67 52 24 18
SERTRALINE HCL 66 31 25 21
CARBIDOPA-LEVODOPA 66 59 25 85
LANTUS 66 65 25 44
ROPINIROLE HCL 65 48 28 60
MORPHINE SULFATE ER 62 22 S2 29 54
PROPRANOLOL HCL 60 38 30 92
FENTANYL 58 57 S2 31 36
RANITIDINE HCL 57 28 32 39
BISOPROLOL-HYDROCHLOROTHIAZIDE 57 52 32 96
DIGOXIN 53 52 34 47
TRAZODONE HCL 51 44 35 22
FLUOXETINE HCL 50 32 36 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.